CPS Technologies Corp. filed SEC Form 8-K: Other Events

false 0000814676 0000814676 2025-10-07 2025-10-07

 

 

FORM 8-K

 

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 7, 2025

 

(Exact Name of Registrant as Specified in its Charter)

 

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

On October 7, 2025, CPS Technologies Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, as representative (the “Representative”) of the several underwriters named therein (collectively, the “Underwriters”), relating to the underwritten public offering by the Company of 3,000,000 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), with an overallotment option for an additional 450,000 shares, at a public offering price per share of $3.00 (the “Offering”). In addition, the Company, and the Company’s directors and executive officers agreed not to sell or transfer any Common Stock without first obtaining the written consent of Roth Capital Partners, LLC, subject to certain exceptions, for 90 days following the closing of the Offering. On October 8, 2025, the Offering closed, and the Company completed the sale and issuance of an aggregate of 3,450,000 shares of Common Stock, including full exercise of the overallotment option.

 

The Company received net proceeds of approximately $9.5 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company currently intends to use the net proceeds from the Offering for general corporate purposes, which may include working capital, capital expenditures, and the expansion of production capacity to meet customer demand, including through a local move to a larger facility.

 

The Offering was made pursuant to the shelf registration statement on Form S-3 (File No. 333-282266) (the “Registration Statement”), a prospectus included in the Registration Statement, the preliminary prospectus supplement, which was filed with the Securities and Exchange Commission (the “SEC”) on October 6, 2025, and a final prospectus supplement, which was filed with the SEC on October 8, 2025.

 

The Underwriting Agreement contains customary representations, warranties, covenants, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, and other obligations of the parties. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. A copy of the Underwriting Agreement is attached as Exhibit 1.1 hereto and is hereby incorporated by reference. The foregoing descriptions of the Underwriting Agreement and lock-up arrangements do not purport to be complete and are qualified in their entirety by reference to such exhibit

 

 

A copy of the legal opinion of Nutter, McClennen & Fish LLP relating to the validity of the issuance and sale of the shares in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

CPS TECHNOLOGIES CORP.                  Dated: October 8, 2025

 

Name: Charles K. Griffith, Jr.

Title: Chief Financial Officer